BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28212806)

  • 1. Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada.
    Huang SJ; Bergin K; Smith AC; Gerrie AS; Bruyere H; Dalal CB; Sugioka DK; Hrynchak M; Ramadan KM; Karsan A; Gillan TL; Toze CL
    Cancer Genet; 2017 Jan; 210():1-8. PubMed ID: 28212806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.
    Wawrzyniak E; Kotkowska A; Blonski JZ; Siemieniuk-Rys M; Ziolkowska E; Giannopoulos K; Robak T; Korycka-Wolowiec A
    Eur J Haematol; 2014 Feb; 92(2):91-101. PubMed ID: 24138550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
    Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
    Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.
    Goy J; Gillan TL; Bruyere H; Huang SJT; Hrynchak M; Karsan A; Ramadan K; Connors J; Toze CL; Gerrie AS
    Clin Lymphoma Myeloma Leuk; 2017 Jun; 17(6):382-389. PubMed ID: 28559149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
    Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
    Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.
    Cavazzini F; Rizzotto L; Sofritti O; Daghia G; Cibien F; Martinelli S; Ciccone M; Saccenti E; Dabusti M; Elkareem AA; Bardi A; Tammiso E; Cuneo A; Rigolin GM
    Leuk Lymphoma; 2012 Jan; 53(1):83-8. PubMed ID: 21767243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization.
    Berkova A; Zemanova Z; Trneny M; Schwarz J; Karban J; Cmunt E; Pavlistova L; Brezinova J; Michalova K
    Neoplasma; 2009; 56(5):455-8. PubMed ID: 19580349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada.
    Huang SJ; Lee LJ; Gerrie AS; Gillan TL; Bruyere H; Hrynchak M; Smith AC; Karsan A; Ramadan KM; Jayasundara KS; Toze CL
    Leuk Res; 2017 Apr; 55():79-90. PubMed ID: 28157628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
    Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
    Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.
    Huang SJ; Gillan TL; Gerrie AS; Hrynchak M; Karsan A; Ramadan K; Smith AC; Toze CL; Bruyere H
    Genes Chromosomes Cancer; 2016 Jan; 55(1):16-24. PubMed ID: 26391112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of clonal evolution in chronic lymphocytic leukemia.
    Koczkodaj D; Popek-Marciniec S; Zmorzyński S; Wąsik-Szczepanek E; Filip AA
    Med Oncol; 2019 Aug; 36(9):79. PubMed ID: 31375939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate-stimulated peripheral blood cells.
    Sánchez J; Aventín A
    Cancer Genet Cytogenet; 2007 May; 175(1):57-60. PubMed ID: 17498559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of genomic abnormalities among 105 patients with chronic lymphocytic leukemia using fluorescence in situ hybridization].
    Wang H; Xu H; Chen Z; Lou J; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):357-360. PubMed ID: 28604954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.
    Van Dyke DL; Werner L; Rassenti LZ; Neuberg D; Ghia E; Heerema NA; Dal Cin P; Dell Aquila M; Sreekantaiah C; Greaves AW; Kipps TJ; Kay NE
    Br J Haematol; 2016 Apr; 173(1):105-13. PubMed ID: 26848054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
    Dewald GW; Brockman SR; Paternoster SF; Bone ND; O'Fallon JR; Allmer C; James CD; Jelinek DF; Tschumper RC; Hanson CA; Pruthi RK; Witzig TE; Call TG; Kay NE
    Br J Haematol; 2003 Apr; 121(2):287-95. PubMed ID: 12694251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
    Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
    Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.
    González-Gascón Y Marín I; Hernández-Sanchez M; Rodríguez-Vicente AE; Puiggros A; Collado R; Luño E; González T; Ruiz-Xivillé N; Ortega M; Gimeno E; Muñoz C; Infante MS; Delgado J; Vargas MT; González M; Bosch F; Espinet B; Hernández-Rivas JM; Hernández JÁ;
    Leuk Lymphoma; 2018 Mar; 59(3):633-642. PubMed ID: 28728469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.